BTG3 and systemic lupus erythematosus: While some studies reported a decreased ANA prevalence after the second dose in a cohort of HCs vaccinated with BNT162b2 [67], Sarin et al. [68] found no new autoantibodies post-vaccination in SLE patients, while Gerosa et al. observed more flares in those with pre-existing anti-dsDNA antibodies.